Funder
GlaxoSmithKline Biologicals
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1–41.
2. World Health Organization. Meningitis. 2023. https://www.who.int/news-room/fact-sheets/detail/meningitis. Accessed 8 Apr 2024.
3. Centers for Disease Control and Prevention. Meningococcal Disease Surveillance. 2023. https://www.cdc.gov/meningococcal/surveillance/index.html. Accessed 8 Apr 2024.
4. Centers for Disease Control and Prevention. Meningococcal Disease Risk Factors. 2023. https://www.cdc.gov/meningococcal/about/risk-factors.html. Accessed 9 Apr 2024.
5. Shen J, Bouee S, Aris E, Emery C, Beck EC. Long-term mortality and state financial support in invasive meningococcal disease-real-world data analysis using the French National Claims Database (SNIIRAM). Infect Dis Ther. 2022;11(1):249–62.